Action SRDX SURMODICS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Surmodics, Inc.

Actions

SRDX

US8688731004

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 06/06/2024 		Varia. 5j. Varia. 1 janv.
41,96 USD -0,07 % Graphique intraday de Surmodics, Inc. -0,33 % +15,43 %
30/05 SURMODICS, INC. : Barrington Research neutre sur le dossier ZM
29/05 SURMODICS, INC. : Needham & Co. neutre sur le dossier ZM

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc.
Shareholder Alert: Ademi LLP investigates whether Surmodics, Inc. has obtained a Fair Price for its Public Shareholders
SRDX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Surmodics to GTCR
Sector Update: Health Care Stocks Lean Lower Premarket Wednesday
Rising Bond Yields Fueling Losses for US Equity Futures Pre-Bell
Sector Update: Health Care
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday After Fed Speaker's Hawkish Comments
SRDX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surmodics, Inc. Is Fair to Shareholders
Top Premarket Gainers
SurModics Agrees to be Acquired by Private Equity Firm GTCR for $627 Million; Shares Rise Pre-Bell
Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million
GTCR LLC entered into a definitive agreement to acquire Surmodics, Inc. for approximately $620 million.
Top Midday Gainers
SurModics: Fiscal Q2 Earnings Snapshot
Earnings Flash (SRDX) SURMODICS Reports Q2 Revenue $32M, vs. Street Est of $28.8M
Earnings Flash (SRDX) SURMODICS Reports Q2 EPS $0.07, vs. Street Est of $-0.32
Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
Surmodics, Inc. Revises Earnings Guidance for the Fiscal Year 2024
Surmodics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
North American Morning Briefing : Traders Wait for -2-
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action SRDX
  4. Actualités Surmodics, Inc.
  5. Autres langues